These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 6360778)

  • 1. Immune abnormalities in diabetic patients not requiring insulin at diagnosis.
    Di Mario U; Irvine WJ; Borsey DQ; Kyner JL; Weston J; Galfo C
    Diabetologia; 1983 Nov; 25(5):392-5. PubMed ID: 6360778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Detection of antibodies against pancreatic islet cells in clinical practice].
    Pánczél P; Külkey O; Luczay A; Bornemisza B; Illyés G; Halmos T; Baranyi E; Blatniczky L; Mészáros J; Kerényi Z; Geró L; Tamás G; Hosszúfalusi N; Horváth L; Madácsy L; Romics L
    Orv Hetil; 1999 Nov; 140(48):2695-701. PubMed ID: 10645715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of islet cell antibodies and HLA-DR phenotypes with diabetes mellitus in adults.
    Gleichmann H; Zörcher B; Greulich B; Gries FA; Henrichs HR; Betrams J; Kolb H
    Diabetologia; 1984 Jul; 27 Suppl():90-2. PubMed ID: 6383926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An association between complement-fixing cytoplasmic islet cell antibodies and endogenous insulin secretion in children with insulin-dependent diabetes mellitus.
    Mustonen A; Knip M; Akerblom HK
    Diabetes; 1983 Aug; 32(8):743-7. PubMed ID: 6347771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Demonstration of islet cell antibodies in apparently non-insulin dependent diabetic patients; a marker for the later development of insulin dependency.
    Katsura H; Itoh N; Hanafusa T; Kono N; Tarui S
    Med J Osaka Univ; 1991 Mar; 40(1-4):67-71. PubMed ID: 1369659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Islet cell cytoplasmic antibodies (ICA) and complement-fixing islet cell cytoplasmic antibodies (CF-ICA) in patients with newly detected type 1 diabetes mellitus of short duration].
    Majkowska L
    Ann Acad Med Stetin; 1990; 36():95-111. PubMed ID: 2099111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Islet cell antibodies, circulating immune complexes and antinuclear antibodies in diabetes mellitus.
    Helmke K; Otten A; Mäser E; Wolf H; Federlin K
    Horm Metab Res; 1987 Jul; 19(7):312-5. PubMed ID: 3305275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relation between insulin antibody and complement-fixing islet cell antibody at clinical diagnosis of IDDM.
    Karjalainen J; Knip M; Mustonen A; Ilonen J; Akerblom HK
    Diabetes; 1986 May; 35(5):620-2. PubMed ID: 3514336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of islet cell surface antibodies using cloned beta cells and comparison of their incidence with that of islet cell cytoplasmic antibodies.
    Grant AM; Harrison DE; Moysey L; Smith D; Ashcroft SJ
    Diabetes Res; 1985 Sep; 2(5):225-9. PubMed ID: 3905186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between serum insulin autoantibodies, islet cell antibodies and Coxsackie-B4 and mumps virus-specific antibodies at the clinical manifestation of type 1 (insulin-dependent) diabetes.
    Karjalainen J; Knip M; Hyöty H; Leinikki P; Ilonen J; Käär ML; Akerblom HK
    Diabetologia; 1988 Mar; 31(3):146-52. PubMed ID: 3286341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GAD 65 antibody but not ICA positivity in adult-onset diabetic patients is associated with early progression to clinical insulin dependency.
    Hatziagelaki E; Jaeger C; Maeser E; Bretzel RG; Federlin K
    Acta Diabetol; 1996 Dec; 33(4):291-4. PubMed ID: 9033970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Islet cell and insulin autoantibodies in organ-specific autoimmune patients. Their behaviour and predictive value for the development of type 1 (insulin-dependent) diabetes mellitus. A 10-year follow-up study.
    Betterle C; Presotto F; Pedini B; Moro L; Slack RS; Zanette F; Zanchetta R
    Diabetologia; 1987 May; 30(5):292-7. PubMed ID: 3301480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cytoplasmic islet-cell antibodies (ICA) and cytoplasmic complement- fixing antibodies (CF-ICA) in patients with newly detected and short-lasting diabetes mellitus type 1].
    Majkowska L; Czekalski S; Skwira J
    Pol Tyg Lek; 1990 May 7-14; 45(19-20):384-8. PubMed ID: 2255656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro inhibition of insulin release mediated by sera with complement-fixing islet cell antibodies belonging to normal first degree relatives of patients with type 1 diabetes.
    Sensi M; Zuccarini O; Spencer KM; Beales P; Pujol-Borrell R; Pozzilli P
    Diabetes Res; 1985 Jan; 2(1):1-4. PubMed ID: 3888494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. UKPDS 25: autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes. UK Prospective Diabetes Study Group.
    Turner R; Stratton I; Horton V; Manley S; Zimmet P; Mackay IR; Shattock M; Bottazzo GF; Holman R
    Lancet; 1997 Nov; 350(9087):1288-93. PubMed ID: 9357409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting insulin-dependent diabetes.
    Tarn AC; Thomas JM; Dean BM; Ingram D; Schwarz G; Bottazzo GF; Gale EA
    Lancet; 1988 Apr; 1(8590):845-50. PubMed ID: 2895363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Islet cell antibodies and insulin autoantibodies in patients treated with oral hypoglycaemic agents.
    Jennings AM; Spencer KM; Dean BM; Wilson RM; Bottazzo GF; Ward JD
    Diabet Med; 1989 Jul; 6(5):434-9. PubMed ID: 2527682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Detection of islet cell antibodies by using avidin-biotin-peroxidase complex technique].
    Yang JL; Huang YQ; Yue Y
    Zhonghua Nei Ke Za Zhi; 1994 Feb; 33(2):92-4. PubMed ID: 8070298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prevalence of islet-cell antibodies and complement-fixing islet-cell antibodies in Japanese diabetics.
    Kobayashi T; Sawano S; Itoh T; Sugimoto T; Tanaka T; Suwa S
    Endocrinol Jpn; 1981 Aug; 28(4):429-33. PubMed ID: 6763893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical time-course and characteristics of islet cell cytoplasmatic antibodies in childhood diabetes.
    Bruining GJ; Molenaar J; Tuk CW; Lindeman J; Bruining HA; Marner B
    Diabetologia; 1984 Jan; 26(1):24-9. PubMed ID: 6368297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.